- امروز : چهارشنبه, ۲۸ آذر , ۱۴۰۳
- برابر با : Wednesday - 18 December - 2024
اخبار ویژه
Silent Damage First: Alzheimer’s Disease Could Have Two Phases
Sports Concussion Outcomes Can Be Made Worse By Depression
Dad’s Use of Diabetes Med Metformin Won’t Raise Birth Defect Risk
Fitness, Activity Boosts Kids’ Mental Health, Too
Exercise in Pregnancy Might Lower Baby’s Odds for Asthma Later
Some IUDs May Raise The Odds for Breast Cancer, But Overall Risk Remains Low
Music Might Speed Your Recovery From Surgery
A Cancer Diagnosis Takes Devastating Toll on Family Finances
Mounjaro (tirzepatide)
GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea
A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.
WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs
Both the World Health Organization and Eli Lilly warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.
Experimental GLP-1 Med Might Be Breakthrough Against Fatty Liver Disease
An experimental 'supercharged' form of popular GLP-1 weight-loss meds could help ease fatty liver disease, a new trial suggests.
Wegovy, Ozempic May Help Curb Alcohol Dependence
Could the blockbuster GLP-1 meds like Wegovy and Ozempic have a role to play in helping people cut down on problem drinking? A new study suggests so.
GLP-1 Weight Loss Meds Might Keep Your Pancreas Healthy
Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says.
Could New Weight-Loss Drugs Be Changing Women’s Taste for Sweets?
Ozempic and Wegovy appear to improve people’s sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests.
Costs, Side Effects Drive Folks to Quit New Weight-Loss Meds
Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows.
Use of GLP-1 Meds Have Risen 7-Fold Among Young Americans
The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds.
